# Scientific objective

Determine whether molecular properties of AZ1–AZ10 provide defensible explanatory or predictive information about the reported Candida albicans MIC differences. Investigate the relationship using evidence appropriate to this small measured series and state what can and cannot be inferred about activity.

# Author-provided scientific guidance

The source calculates molecular properties for AZ1–AZ10, not only AZ9: SI TableS12 contains frontier energies, derived descriptors and dipoles for all ten at gas-phase B3LYP/6-31G(d); Gaussian16 is the disclosed program. Main pp4–7 links frontier/MEP/polarity descriptors to activity and docking, with selected geometry/orbital figures. The old benchmark’s isolated AZ9 reference was only a narrow task, not the scope of the author study. Source formulas require scrutiny: TableS12 prints ΔE=EHOMO−ELUMO but tabulates positive ELUMO−EHOMO differences; it defines μ=−η and ω=η/2, which do not implement the usual finite-difference chemical-potential/electrophilicity definitions μ=−(IP+EA)/2 and ω=μ²/(2η). Label any source-formula reproduction explicitly and distinguish corrected physical definitions; source arithmetic is not a correctness target. Fixed HOMO/dipole versus logP/MW features, ridgeα=1, LOOCV and1000 permutations were V1 additions, not an author validation protocol.

Reproduce the disclosed author baseline within this scope, or justify a substitute scientifically and assess its consequences. Clearly distinguish this reproduction from your additional investigation. Source conclusions are conditional evidence, not an answer that must be affirmed; scientifically justified corrections or unresolved results remain eligible. The V1 benchmark interventions were not part of the author protocol and are not required in this version.

# Public inputs and scientific boundaries

The available sample consists of the ten complete azetidine–pyridazine derivatives and one C. albicans MIC column from the source assay. The supplied neutral singlet graphs define the molecules; any additional state/environment approximation must be justified. Restrict biological conclusions to this assay and sample. Neither a molecular property nor an association in ten compounds proves a target-binding mechanism, cell permeability, clinical efficacy or general antimicrobial activity. Other organisms, docking targets and new analogue design are outside the required question.

Read `data/inputs/systems.json`, `problem_facts.json` and the observational files listed below. These are identity/observation inputs, not an optimized starting-answer set.

- `data/inputs/mic_observations.json`
- `data/inputs/problem_facts.json`
- `data/inputs/systems.json`

The benchmark chemistry toolbox provides scientific/data actions, reviewed native software input routes and agent-authored Python analysis in selected runtimes. Its registered Gaussian and ORCA routes and Python graph/analysis tools are potential resources, not a prescribed workflow. Inspect the available tool catalog and native manuals in the execution environment before choosing a capability. Source authors' software versions do not guarantee identical installed versions. Runtime allocation is supplied by the execution environment; no paper-specific CPU-hour or accuracy budget has been measured here. Record actual usage, failed attempts and unmeasured costs honestly. Public observations are available from the outset and are retrospective data, not a hidden test set. Do not access private evaluation material, another task mode or source answer files.

# Required scientific validation/investigation

Design and carry out an investigation that can substantiate your answer within the stated scope. Choose and justify the model, method, evidence and any further comparisons needed for the claims you make. Explain the relationship between observations and inference, the important unresolved alternatives, and why the evidence is sufficient or insufficient. A supported negative answer or a bounded inability to distinguish explanations is a scientific outcome; a statement of uncertainty without relevant work is not completion.

Validate the identity, conditions, state and numerical meaning of every result used. Claims of equilibrium populations, minima, predictive performance or causal effects require evidence appropriate to those claims. AR selects its research route independently. PR reproduces the disclosed author baseline or explains a scientifically justified substitute and its consequences; additional investigation remains self-designed. The shared scientific-result criteria require neither a particular method nor an author outcome. No fixed hypothesis count, comparison matrix or search order is prescribed. Record concise research decisions linked to actual artifacts and tool traces; do not submit private internal reasoning. No claim of a prospective prediction follows merely from a self-authored timestamp.

# Deliverables

Submit `report/results.json` and a readable `report/report.md` using the accompanying contract. Include structured measured/calculated quantities with units, definitions and conditions, the models actually used, raw input/output or data-analysis artifacts, reproducible analysis, and supported findings. `partial`, `bounded_failure` and `blocked` submissions preserve credit for valid work but do not establish a complete answer. See `submission_guide.md`.
